Related Experiment Video
Updated: Jan 12, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
WTAP promotes the proliferation of multiple myeloma by regulating the hippo pathway through m6A modification of
Han Xu1, Manting Xu1, Jiamin Ding1
1Department of Hematology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Abstract:
Multiple myeloma (MM) remains incurable, largely owing to the lack of effective therapeutic targets. Wilms' tumor 1-associated protein (WTAP) has been implicated in MM tumorigenesis, but its underlying molecular mechanisms remain unclear. This study aimed to elucidate the role of WTAP in MM progression. Bone marrow samples from newly diagnosed MM patients were analyzed. WTAP expression was assessed via Quantitative real-time PCR (qRT-PCR) and Western blot. Cell proliferation was evaluated using EdU and flow cytometry assays, while RNA immunoprecipitation (RIP) confirmed protein interactions. WTAP was overexpressed in MM patients and correlated with poor survival. Its knockdown significantly suppressed MM cell proliferation and inflammation. RIP assays identified MAP6D1 as a potential WTAP target. RNA-seq analysis suggested WTAP regulates MM proliferation via the Hippo signaling pathway. WTAP promotes MM proliferation by targeting MAP6D1 and modulating the Hippo pathway, highlighting its potential as a therapeutic target.
Insights
Wilms
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Multiple myeloma (MM) is an incurable blood cancer with limited therapeutic targets.
- Wilms' tumor 1-associated protein (WTAP) is implicated in MM, but its role is not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms of WTAP in multiple myeloma progression.
- To evaluate WTAP as a potential therapeutic target for MM.
Main Methods:
- Analysis of bone marrow samples from newly diagnosed MM patients.
- Quantitative real-time PCR (qRT-PCR) and Western blot for WTAP expression.
- EdU and flow cytometry for cell proliferation; RNA immunoprecipitation (RIP) for protein interactions.
Main Results:
- WTAP was overexpressed in MM patients and linked to poorer survival.
- WTAP knockdown inhibited MM cell proliferation and inflammation.
- MAP6D1 identified as a WTAP target, suggesting Hippo pathway involvement.
Conclusions:
- WTAP promotes MM proliferation by targeting MAP6D1 and regulating the Hippo signaling pathway.
- WTAP represents a promising therapeutic target for multiple myeloma.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Microtubule Associated Proteins (MAPs)
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
MAPK Signaling Cascades